Metabolic syndrome and coronary artery calcification in renal transplant recipients.
BACKGROUND
Coronary artery calcification (CAC) and metabolic syndrome (MS) have been associated with increased cardiovascular risk. The study objective was to examine the association of MS with CAC presence and progression in renal transplant recipients.


METHODS
We measured the CAC progression in asymptomatic recipients who had no prior history of coronary artery disease.


RESULTS
MS was common (55.4%). Median CAC scores were 0, 33.1, 98, and 261.9 for patients with one, two, three, and four or more positive components of the MS, respectively. Severe CAC scores were more common in recipients with MS (P=0.04). Although recipients with MS had higher mean CAC scores at baseline and significant CAC progression (483 [590.6] vs. 619 [813.8], P=0.01), MS was not an independent predictor of annualized rate of CAC change in a multivariate model.


CONCLUSIONS
Future studies to evaluate if MS treatment improves cardiovascular outcomes are imperative.
Adeseun
Gbemisola A
GA
Renal, Electrolyte, and Hypertension Division, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Rivera
Maria E
ME
Thota
Subhashini
S
Joffe
Marshall
M
Rosas
Sylvia E
SE
D000328:Adult; D015992:Body Mass Index; D002114:Calcinosis / Q000097:blood / Q000150:complications / Q000453:epidemiology*; D003327:Coronary Disease / Q000097:blood / Q000150:complications / Q000453:epidemiology*; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects*; D008055:Lipids / Q000097:blood; D024821:Metabolic Syndrome / Q000097:blood / Q000150:complications / Q000453:epidemiology*; D009765:Obesity / Q000453:epidemiology; D011183:Postoperative Complications / Q000453:epidemiology*; D015995:Prevalence; D014280:Triglycerides / Q000097:blood
D008055:Lipids; D014280:Triglycerides
Circulation. 2002 Dec 17;106(25):3143-421
12485966
Kidney Int. 2006 Aug;70(4):757-64
16788687
Circulation. 2004 Sep 7;110(10):1245-50
15326067
Nephrol Dial Transplant. 2001 May;16(5):1047-52
11328915
J Am Coll Cardiol. 2006 Mar 21;47(6):1093-100
16545636
Diabetes Care. 2001 Apr;24(4):683-9
11315831
Mayo Clin Proc. 1999 Mar;74(3):243-52
10089993
Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):2051-8
11742884
Nephrol Dial Transplant. 2004 Sep;19(9):2307-12
15213315
Kidney Int. 2004 Jul;66(1):441-7
15200454
Hypertension. 2001 Oct;38(4):938-42
11641313
Am J Transplant. 2005 Aug;5(8):1942-7
15996243
Am J Cardiol. 2005 May 15;95(10):1180-6
15877990
Nephrol Dial Transplant. 2006 Jul;21 Suppl 3:iii3-8
16815854
Transplant Proc. 2003 Aug;35(5):1722-4
12962771
Transplant Proc. 2007 Jul-Aug;39(6):1843-6
17692629
Am J Kidney Dis. 2004 Feb;43(2):313-9
14750097
Am J Cardiol. 2005 Oct 17;96(8A):20J-27J
16246650
Kidney Int. 2002 Nov;62(5):1839-47
12371987
Am J Transplant. 2004 Oct;4(10):1675-83
15367224
Am J Kidney Dis. 2006 Aug;48(2):307-13
16860198
Diabetes Care. 2005 Jun;28(6):1445-50
15920066
Am J Nephrol. 2007;27(3):247-52
17389785
Nephrol Dial Transplant. 1997 Jan;12(1):21-4
9027767
Am J Transplant. 2007 Sep;7(9):2158-64
17640315
Transplant Proc. 2006 Mar;38(2):506-8
16549161
Transplantation. 2006 Sep 15;82(5):603-11
16969281
Am J Kidney Dis. 2006 Jul;48(1):134-42
16797396
Clin Exp Nephrol. 2004 Mar;8(1):54-8
15067517
Kidney Int. 2007 Mar;71(5):438-41
17200680
J Am Coll Cardiol. 2003 May 7;41(9):1547-53
12742296
Transplantation. 2007 Jun 27;83(12):1577-81
17589340
Kidney Int. 2000 Jan;57(1):307-13
10620213
Am J Transplant. 2005 Nov;5(11):2710-8
16212631
J Am Soc Nephrol. 2005 Feb;16(2):496-506
15615820